Pharmaceutical

STAT+: FDA advisers vote overwhelmingly against ALS tre...

A panel of independent advisers to the FDA voted against a polarizing potential ...

STAT+: U.S. government’s next-gen Covid effort gives sm...

The U.S. government said it would give a small biotechnology firm, Gritstone bio...

Gene therapy death was caused by an unknown risk of the...

“I don’t think it was foreseeable,” a gene therapy researcher says about the dea...

STAT+: Biogen shutters digital health group, nixes Appl...

Former Biogen employees said that it appeared the vast majority of the digital h...

STAT+: Brigham and Women’s exec opens up about the Dana...

A key Brigham and Women’s executive opened up about the system’s split with Dana...

STAT+: GOP senator probes drug discount programs at Cle...

The top ranking Republican on the Senate health committee is launching an invest...

Listen: Who discovered GLP-1? Plus: BrainStorm at the F...

Listen: Why was chemist Svetlana Mojsov edged out of credit for discovering GLP-...

Exodus of life scientists from academia reaches histori...

New data show the exodus of young life scientists from academia to industry has ...

STAT+: Drug industry payments to eye docs boosted Medic...

Ophthalmologists who accepted payments from drug companies were less likely to p...

She got off dialysis. Her doctor thinks others with acu...

Dialysis impacts quality of life and can lead to infection and heart damage. Now...

Did you have Obamacare on your GOP debate bingo card?

On health care, the second GOP debate spanned drug prices, the opioid crisis, ge...

Flu, Covid vaccination rates decline, as U.S. health of...

Vaccination rates against flu and Covid-19 have declined since earlier in the pa...

STAT+: Pharmalittle: FDA advisers vote overwhelmingly a...

A FDA advisory panel voted overwhelmingly against a polarizing potential treatme...

Machine learning could help predict risk of preterm bir...

Researchers applied machine learning methods to streams of data about sleep patt...

Opinion: Congress could stop free public access to gove...

Every year, Americans invest hundreds of billions in federal research that they ...

STAT+: What will Novo’s VC do with its influx of cash? ...

Novo Holdings has tasked its investment arm with taking the influx of Wegovy rev...